Home
>
National Drug Code (NDC)
>
Nplate
Nplate - 55513-221-01 - (romiplostim)
Drug Information of Nplate
| Product NDC: | 55513-221 |
| Proprietary Name: | Nplate |
| Non Proprietary Name: | romiplostim |
| Active Ingredient(s): | 250 ug/.5mL & nbsp; romiplostim |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nplate
| Product NDC: | 55513-221 |
| Labeler Name: | Amgen Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125268 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20080825 |
Package Information of Nplate
| Package NDC: | 55513-221-01 |
| Package Description: | 1 VIAL in 1 CARTON (55513-221-01) > .5 mL in 1 VIAL |
NDC Information of Nplate
| NDC Code | 55513-221-01 |
| Proprietary Name | Nplate |
| Package Description | 1 VIAL in 1 CARTON (55513-221-01) > .5 mL in 1 VIAL |
| Product NDC | 55513-221 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | romiplostim |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20080825 |
| Marketing Category Name | BLA |
| Labeler Name | Amgen Inc |
| Substance Name | ROMIPLOSTIM |
| Strength Number | 250 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoiesis Stimulating Agent [EPC],Thrombopoietin Receptor Agonists [MoA],Thrombopoietin Receptor Interactions [MoA] |
